Accumulating evidence supports that tumor or tumor stroma-derived free or microvesicle wrapped soluble mediators (IL-10, indolamine-2,3-deoxigenase, ROS, ArgI, PGE2) and even cell junction proximity with myeloid cells endow TAMs and MDSCSs with immunosuppressive phenotype dampening both innate and adaptive tumor cell clearance [44,62,63]. The gene discussed is LNCARGI; the disease is neoplasm.